KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Novavax (NVAX) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Novavax (NVAX) over the last 14 years, with Q4 2022 value amounting to $86.8 million.

  • Novavax's Shares Outstanding rose 1357.19% to $86.8 million in Q4 2022 from the same period last year, while for Dec 2022 it was $86.8 million, marking a year-over-year increase of 1357.19%. This contributed to the annual value of $86.8 million for FY2022, which is 1357.19% up from last year.
  • Latest data reveals that Novavax reported Shares Outstanding of $86.8 million as of Q4 2022, which was up 1357.19% from $79.2 million recorded in Q3 2022.
  • Novavax's 5-year Shares Outstanding high stood at $86.8 million for Q4 2022, and its period low was $17.4 million during Q1 2018.
  • For the 5-year period, Novavax's Shares Outstanding averaged around $52.7 million, with its median value being $62.3 million (2020).
  • Its Shares Outstanding has fluctuated over the past 5 years, first soared by 16074.24% in 2020, then soared by 425.28% in 2022.
  • Over the past 5 years, Novavax's Shares Outstanding (Quarter) stood at $19.2 million in 2018, then skyrocketed by 68.35% to $32.4 million in 2019, then soared by 120.22% to $71.4 million in 2020, then rose by 7.12% to $76.4 million in 2021, then grew by 13.57% to $86.8 million in 2022.
  • Its last three reported values are $86.8 million in Q4 2022, $79.2 million for Q3 2022, and $78.8 million during Q2 2022.